Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 11 |
NetGPI | no | yes: 0, no: 11 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005737 | cytoplasm | 2 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 1 |
Related structures:
AlphaFold database: A4HL12
Term | Name | Level | Count |
---|---|---|---|
GO:0006139 | nucleobase-containing compound metabolic process | 3 | 12 |
GO:0006396 | RNA processing | 6 | 12 |
GO:0006399 | tRNA metabolic process | 7 | 12 |
GO:0006725 | cellular aromatic compound metabolic process | 3 | 12 |
GO:0006807 | nitrogen compound metabolic process | 2 | 12 |
GO:0008033 | tRNA processing | 8 | 12 |
GO:0008152 | metabolic process | 1 | 12 |
GO:0009987 | cellular process | 1 | 12 |
GO:0016070 | RNA metabolic process | 5 | 12 |
GO:0032259 | methylation | 2 | 12 |
GO:0034470 | ncRNA processing | 7 | 12 |
GO:0034641 | cellular nitrogen compound metabolic process | 3 | 12 |
GO:0034660 | ncRNA metabolic process | 6 | 12 |
GO:0043170 | macromolecule metabolic process | 3 | 12 |
GO:0044237 | cellular metabolic process | 2 | 12 |
GO:0044238 | primary metabolic process | 2 | 12 |
GO:0046483 | heterocycle metabolic process | 3 | 12 |
GO:0071704 | organic substance metabolic process | 2 | 12 |
GO:0090304 | nucleic acid metabolic process | 4 | 12 |
GO:1901360 | organic cyclic compound metabolic process | 3 | 12 |
GO:0001510 | RNA methylation | 4 | 1 |
GO:0006400 | tRNA modification | 6 | 1 |
GO:0009451 | RNA modification | 5 | 1 |
GO:0030488 | tRNA methylation | 5 | 1 |
GO:0043412 | macromolecule modification | 4 | 1 |
GO:0043414 | macromolecule methylation | 3 | 1 |
GO:0044260 | obsolete cellular macromolecule metabolic process | 3 | 1 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003824 | catalytic activity | 1 | 12 |
GO:0008168 | methyltransferase activity | 4 | 12 |
GO:0016740 | transferase activity | 2 | 12 |
GO:0016741 | transferase activity, transferring one-carbon groups | 3 | 12 |
GO:0008173 | RNA methyltransferase activity | 4 | 1 |
GO:0008175 | tRNA methyltransferase activity | 5 | 1 |
GO:0140098 | catalytic activity, acting on RNA | 3 | 1 |
GO:0140101 | catalytic activity, acting on a tRNA | 4 | 1 |
GO:0140640 | catalytic activity, acting on a nucleic acid | 2 | 1 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 271 | 275 | PF00656 | 0.411 |
CLV_NRD_NRD_1 | 246 | 248 | PF00675 | 0.293 |
CLV_NRD_NRD_1 | 263 | 265 | PF00675 | 0.573 |
CLV_NRD_NRD_1 | 86 | 88 | PF00675 | 0.320 |
CLV_PCSK_FUR_1 | 244 | 248 | PF00082 | 0.417 |
CLV_PCSK_FUR_1 | 86 | 90 | PF00082 | 0.451 |
CLV_PCSK_KEX2_1 | 244 | 246 | PF00082 | 0.306 |
CLV_PCSK_KEX2_1 | 263 | 265 | PF00082 | 0.588 |
CLV_PCSK_KEX2_1 | 277 | 279 | PF00082 | 0.364 |
CLV_PCSK_KEX2_1 | 86 | 88 | PF00082 | 0.314 |
CLV_PCSK_PC1ET2_1 | 277 | 279 | PF00082 | 0.421 |
CLV_PCSK_PC1ET2_1 | 88 | 90 | PF00082 | 0.304 |
CLV_PCSK_PC7_1 | 273 | 279 | PF00082 | 0.417 |
DEG_Nend_UBRbox_1 | 1 | 4 | PF02207 | 0.374 |
DEG_SIAH_1 | 65 | 73 | PF03145 | 0.199 |
DEG_SPOP_SBC_1 | 41 | 45 | PF00917 | 0.320 |
DOC_CYCLIN_yCln2_LP_2 | 195 | 201 | PF00134 | 0.318 |
DOC_MAPK_MEF2A_6 | 137 | 146 | PF00069 | 0.323 |
DOC_USP7_MATH_1 | 72 | 76 | PF00917 | 0.435 |
DOC_USP7_MATH_1 | 80 | 84 | PF00917 | 0.307 |
DOC_USP7_UBL2_3 | 186 | 190 | PF12436 | 0.393 |
DOC_WW_Pin1_4 | 194 | 199 | PF00397 | 0.366 |
DOC_WW_Pin1_4 | 211 | 216 | PF00397 | 0.269 |
DOC_WW_Pin1_4 | 62 | 67 | PF00397 | 0.451 |
LIG_14-3-3_CanoR_1 | 137 | 144 | PF00244 | 0.466 |
LIG_14-3-3_CanoR_1 | 183 | 189 | PF00244 | 0.360 |
LIG_14-3-3_CanoR_1 | 264 | 272 | PF00244 | 0.668 |
LIG_14-3-3_CanoR_1 | 49 | 53 | PF00244 | 0.204 |
LIG_14-3-3_CanoR_1 | 79 | 85 | PF00244 | 0.199 |
LIG_Actin_WH2_2 | 151 | 168 | PF00022 | 0.199 |
LIG_CaM_NSCaTE_8 | 223 | 230 | PF13499 | 0.309 |
LIG_deltaCOP1_diTrp_1 | 121 | 126 | PF00928 | 0.425 |
LIG_deltaCOP1_diTrp_1 | 209 | 218 | PF00928 | 0.391 |
LIG_deltaCOP1_diTrp_1 | 221 | 226 | PF00928 | 0.425 |
LIG_FHA_1 | 136 | 142 | PF00498 | 0.326 |
LIG_FHA_1 | 190 | 196 | PF00498 | 0.320 |
LIG_FHA_1 | 226 | 232 | PF00498 | 0.331 |
LIG_FHA_1 | 36 | 42 | PF00498 | 0.391 |
LIG_FHA_2 | 266 | 272 | PF00498 | 0.420 |
LIG_LIR_Gen_1 | 220 | 231 | PF02991 | 0.390 |
LIG_LIR_Nem_3 | 220 | 226 | PF02991 | 0.304 |
LIG_LIR_Nem_3 | 36 | 40 | PF02991 | 0.318 |
LIG_MYND_3 | 117 | 121 | PF01753 | 0.420 |
LIG_PTB_Apo_2 | 31 | 38 | PF02174 | 0.320 |
LIG_RPA_C_Fungi | 241 | 253 | PF08784 | 0.199 |
LIG_SH2_GRB2like | 32 | 35 | PF00017 | 0.425 |
LIG_SH2_SRC | 32 | 35 | PF00017 | 0.425 |
LIG_SH2_STAT5 | 32 | 35 | PF00017 | 0.339 |
LIG_SH2_STAT5 | 40 | 43 | PF00017 | 0.266 |
LIG_UBA3_1 | 150 | 159 | PF00899 | 0.291 |
MOD_CK1_1 | 182 | 188 | PF00069 | 0.325 |
MOD_CK1_1 | 59 | 65 | PF00069 | 0.435 |
MOD_CK2_1 | 265 | 271 | PF00069 | 0.427 |
MOD_CK2_1 | 79 | 85 | PF00069 | 0.462 |
MOD_GlcNHglycan | 170 | 173 | PF01048 | 0.324 |
MOD_GlcNHglycan | 175 | 178 | PF01048 | 0.331 |
MOD_GlcNHglycan | 57 | 61 | PF01048 | 0.274 |
MOD_GSK3_1 | 108 | 115 | PF00069 | 0.362 |
MOD_GSK3_1 | 131 | 138 | PF00069 | 0.379 |
MOD_GSK3_1 | 173 | 180 | PF00069 | 0.313 |
MOD_GSK3_1 | 189 | 196 | PF00069 | 0.320 |
MOD_GSK3_1 | 35 | 42 | PF00069 | 0.328 |
MOD_GSK3_1 | 4 | 11 | PF00069 | 0.451 |
MOD_GSK3_1 | 55 | 62 | PF00069 | 0.121 |
MOD_GSK3_1 | 93 | 100 | PF00069 | 0.353 |
MOD_N-GLC_1 | 33 | 38 | PF02516 | 0.393 |
MOD_NEK2_1 | 131 | 136 | PF00069 | 0.199 |
MOD_NEK2_2 | 48 | 53 | PF00069 | 0.204 |
MOD_NEK2_2 | 93 | 98 | PF00069 | 0.362 |
MOD_PIKK_1 | 35 | 41 | PF00454 | 0.451 |
MOD_PKA_1 | 88 | 94 | PF00069 | 0.390 |
MOD_PKA_2 | 112 | 118 | PF00069 | 0.335 |
MOD_PKA_2 | 136 | 142 | PF00069 | 0.199 |
MOD_PKA_2 | 182 | 188 | PF00069 | 0.328 |
MOD_PKA_2 | 272 | 278 | PF00069 | 0.412 |
MOD_PKA_2 | 48 | 54 | PF00069 | 0.220 |
MOD_PKA_2 | 88 | 94 | PF00069 | 0.390 |
MOD_Plk_1 | 106 | 112 | PF00069 | 0.425 |
MOD_Plk_1 | 14 | 20 | PF00069 | 0.320 |
MOD_Plk_4 | 112 | 118 | PF00069 | 0.211 |
MOD_Plk_4 | 131 | 137 | PF00069 | 0.414 |
MOD_Plk_4 | 222 | 228 | PF00069 | 0.387 |
MOD_Plk_4 | 233 | 239 | PF00069 | 0.393 |
MOD_Plk_4 | 48 | 54 | PF00069 | 0.212 |
MOD_Plk_4 | 72 | 78 | PF00069 | 0.199 |
MOD_Plk_4 | 93 | 99 | PF00069 | 0.356 |
MOD_ProDKin_1 | 194 | 200 | PF00069 | 0.366 |
MOD_ProDKin_1 | 211 | 217 | PF00069 | 0.269 |
MOD_ProDKin_1 | 62 | 68 | PF00069 | 0.451 |
MOD_SUMO_for_1 | 144 | 147 | PF00179 | 0.304 |
TRG_ER_diArg_1 | 244 | 247 | PF00400 | 0.279 |
TRG_ER_diArg_1 | 263 | 265 | PF00400 | 0.615 |
TRG_ER_diArg_1 | 86 | 89 | PF00400 | 0.451 |
TRG_NLS_MonoExtN_4 | 86 | 91 | PF00514 | 0.427 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1PB24 | Leptomonas seymouri | 63% | 99% |
A0A1X0NNC3 | Trypanosomatidae | 27% | 81% |
A0A1X0NRX8 | Trypanosomatidae | 50% | 93% |
A0A3R7NUS4 | Trypanosoma rangeli | 51% | 100% |
A0A3S7X653 | Leishmania donovani | 79% | 100% |
A4I8J3 | Leishmania infantum | 79% | 100% |
D0AAM5 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 52% | 94% |
E9B3F3 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 79% | 100% |
Q4Q4P7 | Leishmania major | 80% | 100% |
Q9UTA5 | Schizosaccharomyces pombe (strain 972 / ATCC 24843) | 24% | 100% |
V5DMF2 | Trypanosoma cruzi | 52% | 100% |